Repligen Corporation (RGEN)
NASDAQ: RGEN · Real-Time Price · USD
132.02
-1.53 (-1.15%)
At close: Jun 18, 2026, 4:00 PM EDT
128.00
-4.02 (-3.04%)
After-hours: Jun 18, 2026, 5:57 PM EDT
Repligen Revenue
Repligen had revenue of $194.26M in the quarter ending March 31, 2026, with 14.83% growth. This brings the company's revenue in the last twelve months to $763.34M, up 17.36% year-over-year. In the year 2025, Repligen had annual revenue of $738.26M with 16.36% growth.
Revenue (ttm)
$763.34M
Revenue Growth
+17.36%
P/S Ratio
9.76
Revenue / Employee
$381,670
Employees
2,000
Market Cap
7.45B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 738.26M | 103.82M | 16.36% |
| Dec 31, 2024 | 634.44M | 2.08M | 0.33% |
| Dec 31, 2023 | 632.36M | -169.17M | -21.11% |
| Dec 31, 2022 | 801.54M | 131.00M | 19.54% |
| Dec 31, 2021 | 670.53M | 304.27M | 83.08% |
| Dec 31, 2020 | 366.26M | 96.02M | 35.53% |
| Dec 31, 2019 | 270.25M | 76.21M | 39.28% |
| Dec 31, 2018 | 194.03M | 52.80M | 37.38% |
| Dec 31, 2017 | 141.24M | 36.70M | 35.10% |
| Dec 31, 2016 | 104.54M | 21.00M | 25.14% |
| Dec 31, 2015 | 83.54M | 19.99M | 31.45% |
| Dec 31, 2014 | 63.55M | -4.62M | -6.78% |
| Dec 31, 2013 | 68.17M | 5.90M | 9.48% |
| Dec 31, 2012 | 62.27M | 34.98M | 128.16% |
| Mar 31, 2011 | 27.29M | 6.32M | 30.14% |
| Mar 31, 2010 | 20.97M | -8.39M | -28.58% |
| Mar 31, 2009 | 29.36M | 10.07M | 52.16% |
| Mar 31, 2008 | 19.30M | 5.22M | 37.10% |
| Mar 31, 2007 | 14.07M | 1.16M | 9.01% |
| Mar 31, 2006 | 12.91M | 3.55M | 37.94% |
| Mar 31, 2005 | 9.36M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Baxter International | 11.32B |
| Solventum | 8.26B |
| Avantor | 6.55B |
| Bausch + Lomb | 5.21B |
| The Cooper Companies | 4.23B |
| Align Technology | 4.10B |
| AptarGroup | 3.87B |
| MiniMed Group | 3.10B |
RGEN News
- 16 days ago - Repligen Transcript: 46th Annual William Blair Growth Stock Conference - Transcripts
- 16 days ago - Repligen Slides: 46th Annual William Blair Growth Stock Conference - Filings
- 16 days ago - Repligen price target lowered to $150 from $170 at HSBC - TheFly
- 18 days ago - Repligen assumed with an Outperform at Wolfe Research - TheFly
- 4 weeks ago - Repligen Corporation to Present at William Blair 46th Annual Growth Stock Conference - GlobeNewsWire
- 4 weeks ago - Repligen Announces Publication of the Company's 2025 Corporate Sustainability Report - GlobeNewsWire
- 5 weeks ago - Repligen resumed with an Outperform at RBC Capital - TheFly
- 5 weeks ago - Repligen Transcript: AGM 2026 - Transcripts